DocuSign, Inc. (NASDAQ:DOCU) CFO Sells $758,160.00 in Stock

DocuSign, Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.77, for a total value of $758,160.00. Following the sale, the chief financial officer now owns 101,439 shares in the company, valued at approximately $9,613,374.03. This represents a 7.31 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Blake Jeffrey Grayson also recently made the following trade(s):

• On Tuesday, October 15th, Blake Jeffrey Grayson sold 9,552 shares of DocuSign stock. The stock was sold at an average price of $68.80, for a total value of $657,177.60.
• On Wednesday, September 18th, Blake Jeffrey Grayson sold 14,036 shares of DocuSign stock. The stock was sold at an average price of $55.47, for a total transaction of $778,576.92.

DocuSign Stock Performance

DOCU opened at $98.17 on Wednesday. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The stock has a market capitalization of $19.83 billion, a PE ratio of 20.24, a price-to-earnings-growth ratio of 8.72 and a beta of 0.92. The stock’s 50 day moving average price is $79.37 and its 200-day moving average price is $64.02.

Analysts Set New Price Targets

Several research analysts have recently weighed in on DOCU shares. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Piper Sandler increased their price target on shares of DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. JPMorgan Chase & Co. increased their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $90.00 target price (up previously from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Finally, Citigroup lifted their price target on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, DocuSign currently has an average rating of “Hold” and a consensus target price of $92.45.

Institutional Trading of DocuSign

Several large investors have recently bought and sold shares of DOCU. J.W. Cole Advisors Inc. lifted its position in DocuSign by 2.0% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock valued at $493,000 after acquiring an additional 155 shares during the period. Resonant Capital Advisors LLC increased its position in DocuSign by 0.9% during the third quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock valued at $1,088,000 after acquiring an additional 157 shares during the last quarter. Optimist Retirement Group LLC lifted its holdings in DocuSign by 3.8% in the third quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock valued at $274,000 after acquiring an additional 161 shares during the period. V Square Quantitative Management LLC grew its stake in shares of DocuSign by 6.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock valued at $187,000 after purchasing an additional 172 shares during the period. Finally, Dakota Wealth Management lifted its stake in shares of DocuSign by 0.8% in the 2nd quarter. Dakota Wealth Management now owns 23,022 shares of the company’s stock worth $1,232,000 after purchasing an additional 181 shares during the period. 77.64% of the stock is owned by institutional investors.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.